查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1768948

全球食道支架市场

Esophageal Stents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年全球食道支架市场规模将达1.227亿美元

全球食道支架市场规模预计在2024年为8,910万美元，预计2030年将达到1.227亿美元，2024年至2030年的复合年增长率为5.5%。医院是本报告分析的细分市场之一，预计其复合年增长率为5.8%，到分析期结束时规模将达到8,150万美元。专科诊所的复合年增长率预计在分析期间为5.1%。

美国市场规模估计为 2,320 万美元，中国市场预计复合年增长率为 8.4%

美国食道支架市场规模预计在2024年达到2,320万美元。作为世界第二大经济体，中国预计在2030年达到2,760万美元的市场规模，在2024-2030年的分析期内，复合年增长率将达到8.4%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个国家的复合年增长率分别为3.3%和4.5%。在欧洲，预计德国的复合年增长率为4.0%。

全球食道支架市场－主要趋势与驱动因素摘要

什么是食道支架？

食道支架是一种置入食道的管状装置，用于维持因恶性肿瘤、良性狭窄或其他解剖异常导致食道阻塞患者的管腔通畅性。它们在缓解吞嚥困难等严重影响患者生活品质和营养状况的症状方面发挥着重要作用。食道支架通常用于治疗食道癌（肿瘤阻塞食物通道）或良性病变，例如因长期接触酸性物质并随后形成疤痕组织而引起的消化性狭窄。它们也用于治疗气管食道瘘和食道穿孔等併发症，作为更精准治疗的过渡手段或提高患者舒适度的安宁疗护措施。食道支架由多种材料製成，包括镍钛合金（一种可自膨胀的柔性合金）以及覆盖有硅胶以防止组织浸润的金属。这些支架有覆膜支架和无覆膜支架两种类型。覆膜支架旨在防止肿瘤进展至管腔并控制渗漏，而无覆膜支架则可在良性狭窄的情况下提供更牢固的固定。根据临床情况，支架置入可在内镜或萤光透视引导下进行，目的是即时缓解症状并恢復经口进食。作为一种多功能且微创的解决方案，食道支架已成为治疗复杂食道疾病的重要选择，兼具治癒和缓解的益处。

科技进步如何改善食道支架的功能？

技术进步彻底改变了食道支架的设计和应用，提高了安全性、有效性和患者预后。其中最重要的进展之一是全覆膜自膨式金属支架 (SEMS) 的引入，它能够在提供最佳支撑的同时减少肿瘤扩散和食物卡阻等併发症。镍钛合金等先进材料的使用，以其超弹性和形状记忆特性而闻名，使製造商能够製造出精确贴合食道不规则解剖结构的支架，最大限度地降低移位风险并最大限度地提高患者的舒适度。有些支架配备了防逆流阀，透过预防胃食道逆流（恶性狭窄患者中常见的逆流）来改善术后生活品质。硅胶和聚氨酯等涂层材料的创新也至关重要，它们提供了光滑的内表面，从而减少生物膜形成并防止支架阻塞。此外，将药物释放型技术融入食道支架也是近期的突破。这些支架上涂有化疗和抗增殖剂，可防止组织增生和狭窄復发，从而延长支架的使用寿命。另一项重大进展是生物分解性支架的开发，这种支架会随着时间的推移逐渐溶解，使其成为治疗不需要移除手术的良性疾病的理想选择。支架输送系统的改进也有助于提高支架置入的准确性和安全性。现代输送系统包括控释机制、改进的渗透性（以便更好地可视化）和预装导管导引线等功能，使内视镜医师能够更精确地放置支架，即使在具有挑战性的解剖结构中也是如此。这些技术进步正在将食道支架转变为高度复杂的设备，可以治疗更广泛的食道疾病，并减少併发症。

病患人口结构与治疗方法的改变如何影响食道支架市场？

由于患者人口结构的变化、食道癌盛行率的上升以及治疗模式的转变，食道支架市场正在迅速发展。全球食道癌，尤其是与胃食道逆流症 (GERD) 和肥胖相关的腺癌的发生率上升，推动了对食道支架等有效安宁疗护解决方案的需求。老龄化人口更容易患恶性和良性食道疾病，进一步增加了对长期治疗方案的需求，以确保营养摄取并减少吞嚥障碍。这些人口结构的变化促使医疗保健提供者优先考虑提高生活品质的干预措施，使食道置入术成为无法手术的癌症病例姑息治疗的首选方案。同时，治疗方法的改变也影响市场。例如，由于併发症风险降低、恢復时间更短以及与内视镜手术相关的成本更低，内视镜置入术越来越受到比侵入性更强的外科手术的青睐。这使得它不仅用于治疗恶性病例，还用于治疗良性狭窄、难治性食道静脉曲张和术后吻合口漏。此外，以患者为中心的治疗模式正在影响产品开发，强调易于插入、患者耐受性良好、术后併发症更少的支架。这种转变导致支架设计具有更好的固定性、更柔软的材质以减少溃疡形成，以及创新的防移位功能以确保最佳定位。新兴市场越来越多地采用微创支架置入术，这也推动了成长，因为这些地区对医疗保健的投资不断增加，并且对食道疾病先进治疗方案的认识不断提高。

推动食道支架市场成长的关键因素有哪些？

食道支架市场的成长受到多种关键因素的推动，包括食道癌盛行率的上升、支架技术的进步以及微创治疗的日益普及。吸烟、大量饮酒和慢性胃酸倒流等生活习惯会增加食道癌的发生率，尤其是在已开发国家。这导致对安宁疗护的需求增加，以缓解吞嚥障碍并提高晚期癌症患者的生活品质。诸如开发具有增强的灵活性和抗迁移性能的自膨式金属支架等技术创新也在扩大食道支架的临床应用方面发挥了关键作用。药物释放型和生物分解性支架的加入为治疗良性疾病和预防血管再阻塞提供了新的治疗选择，进一步刺激了市场需求。另一个主要成长要素是内视镜手术的广泛应用，这种手术比传统手术侵入性更小，恢復时间更快。随着越来越多的医疗机构将内视镜支架置入置入术作为治疗良恶性食道阻塞的标准方法，先进支架的需求也随之飙升。此外，医疗基础设施的不断扩张、医疗支出的不断增长以及新兴市场食道疾病的盛行率不断上升，也为市场成长创造了新的机会。价值导向型医疗保健的趋势也推动了人们对支架的兴趣，因为支架能够改善长期疗效、降低併发症发生率，为食道疾病的治疗提供经济高效的解决方案。这些市场驱动因素正在改变食道支架市场，随着全球医疗体系持续优先考虑食道疾病的微创解决方案，预计该市场将持续扩张。

部分

最终使用者（医院、专科诊所、门诊手术中心）

受访公司范例

  • Andratec GmbH
  • Boston Scientific Corporation
  • BVM Medical Limited
  • CR Bard, Inc.
  • Cook Group Incorporated
  • Ella-CS, sro
  • Endo-Flex GmbH
  • MITech
  • Merit Medical Systems, Inc.
  • Taewoong Medical Co., Ltd.

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 并未遵循典型的 LLM 或特定产业的 SLM查询，而是建立了一个从全球专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP17707

Global Esophageal Stents Market to Reach US$122.7 Million by 2030

The global market for Esophageal Stents estimated at US$89.1 Million in the year 2024, is expected to reach US$122.7 Million by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$81.5 Million by the end of the analysis period. Growth in the Specialty Clinics segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$23.2 Million While China is Forecast to Grow at 8.4% CAGR

The Esophageal Stents market in the U.S. is estimated at US$23.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.6 Million by the year 2030 trailing a CAGR of 8.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Esophageal Stents Market - Key Trends and Drivers Summarized

What Are Esophageal Stents and Why Are They Used?

Esophageal stents are tubular devices inserted into the esophagus to maintain luminal patency in patients suffering from esophageal obstructions caused by malignant tumors, benign strictures, or other anatomical abnormalities. They play a critical role in alleviating symptoms like dysphagia (difficulty swallowing), which can severely impact a patient’s quality of life and nutritional status. Esophageal stents are typically used in cases of esophageal cancer, where the tumor obstructs the passage of food, or in benign conditions such as peptic strictures, which result from prolonged acid exposure and subsequent scar tissue formation. They can also be utilized to manage complications like tracheoesophageal fistulas or esophageal perforations, serving as a bridge to more definitive treatment or as a palliative measure to enhance the patient’s comfort. Esophageal stents are made from various materials such as nitinol, a flexible alloy that allows for self-expansion, or silicone-covered metal, which helps prevent tissue ingrowth. These stents come in both covered and uncovered variants: covered stents are designed to block tumor growth into the lumen and manage leaks, while uncovered stents provide a firmer anchorage in cases of benign strictures. Depending on the clinical scenario, stent placement can be performed endoscopically or under fluoroscopic guidance, with the aim of immediate symptomatic relief and the restoration of oral intake. As a versatile and minimally invasive solution, esophageal stents have become an essential option in managing complex esophageal conditions, offering both therapeutic and palliative benefits.

How Are Technological Advancements Improving the Functionality of Esophageal Stents?

Technological advancements have revolutionized the design and application of esophageal stents, enhancing their safety, effectiveness, and overall patient outcomes. One of the most significant developments is the introduction of fully covered self-expanding metal stents (SEMS), which provide optimal support while reducing complications such as tumor ingrowth and food impaction. The use of advanced materials like nitinol, known for its superelasticity and shape memory properties, has allowed manufacturers to create stents that conform precisely to the irregular anatomy of the esophagus, minimizing the risk of migration and maximizing patient comfort. Some stents now feature anti-reflux valves, which prevent gastroesophageal reflux-a common issue in patients with malignant strictures-thus improving their quality of life post-procedure. Innovations in coating materials, such as silicone or polyurethane, have also been pivotal, providing a smooth inner surface that reduces biofilm formation and prevents stent obstruction. Moreover, the integration of drug-eluting technology into esophageal stents is a recent breakthrough. These stents are coated with chemotherapeutic agents or anti-proliferative drugs to prevent tissue hyperplasia and recurrent stricture formation, extending the functional lifespan of the stent. Another key advancement is the development of biodegradable stents, which gradually dissolve over time, making them ideal for treating benign conditions without the need for removal procedures. Improvements in stent delivery systems have also contributed to the increased precision and safety of stent placement. Modern delivery systems are equipped with features such as controlled release mechanisms, enhanced radiopacity for better visualization, and preloaded guidewires, enabling endoscopists to deploy stents more accurately even in challenging anatomies. These technological strides are transforming esophageal stents into highly sophisticated devices that address a broader range of esophageal disorders with fewer complications.

How Are Shifting Patient Demographics and Treatment Approaches Impacting the Esophageal Stent Market?

The esophageal stent market is evolving rapidly, driven by changes in patient demographics, rising prevalence of esophageal cancers, and shifts in treatment paradigms. The global increase in esophageal cancer cases, especially adenocarcinoma linked to gastroesophageal reflux disease (GERD) and obesity, has led to a heightened demand for effective palliative solutions like esophageal stents. An aging population, which is more susceptible to both malignant and benign esophageal conditions, has further fueled the need for long-term management options that can ensure nutritional intake and reduce dysphagia. This demographic shift has prompted healthcare providers to prioritize interventions that enhance the quality of life, making esophageal stenting a preferred choice for palliative care in inoperable cancer cases. Simultaneously, changes in treatment approaches are also influencing the market. For instance, there is an increasing preference for endoscopic stenting over more invasive surgical procedures due to the reduced risk of complications, shorter recovery times, and lower costs associated with endoscopic techniques. This has expanded the use of esophageal stents in not only malignant cases but also in treating benign strictures, refractory esophageal varices, and postoperative anastomotic leaks. Moreover, patient-centric care models are shaping product development, with a growing emphasis on stents that offer ease of insertion, better patient tolerance, and minimal post-procedure complications. This shift has led to the design of stents with improved anchorage, softer materials to reduce ulceration, and innovative anti-migration features that ensure optimal positioning. The increasing adoption of minimally invasive stenting procedures in emerging markets is also driving growth, as these regions experience rising healthcare investment and a growing awareness of advanced treatment options for esophageal conditions.

What Are the Key Growth Drivers in the Esophageal Stent Market?

The growth in the esophageal stent market is driven by several critical factors, including the rising incidence of esophageal cancer, advancements in stent technology, and the increasing adoption of minimally invasive treatments. One of the primary drivers is the global surge in esophageal cancer cases, particularly in developed countries, where lifestyle factors such as smoking, heavy alcohol use, and chronic acid reflux have contributed to a higher incidence of adenocarcinoma. This has led to an increased need for palliative care options that can alleviate dysphagia and enhance the quality of life for patients in advanced stages of cancer. Technological innovations, such as the development of self-expanding metal stents with enhanced flexibility and anti-migration properties, are also playing a pivotal role in expanding the clinical applications of esophageal stents. The incorporation of drug-eluting and biodegradable stents is providing new therapeutic options for managing benign conditions and preventing restenosis, further boosting market demand. Another significant growth driver is the widespread adoption of endoscopic procedures, which are less invasive than traditional surgery and associated with faster recovery times. As more healthcare providers embrace endoscopic stenting as the standard approach for treating both malignant and benign esophageal obstructions, the demand for advanced stents has surged. Furthermore, the expansion of healthcare infrastructure in emerging markets, along with increased healthcare expenditure and the rising prevalence of esophageal disorders, is creating new opportunities for market growth. The trend toward value-based healthcare is also driving interest in stents that offer improved long-term outcomes and reduced complication rates, making them a cost-effective solution in the management of esophageal diseases. These diverse growth drivers are transforming the esophageal stent market, positioning it for sustained expansion as healthcare systems worldwide continue to prioritize minimally invasive solutions for esophageal pathologies.

SCOPE OF STUDY:

The report analyzes the Esophageal Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Andratec GmbH
  • Boston Scientific Corporation
  • BVM Medical Limited
  • C. R. Bard, Inc.
  • Cook Group Incorporated
  • Ella - CS, s.r.o.
  • Endo-Flex GmbH
  • M.I.Tech
  • Merit Medical Systems, Inc.
  • Taewoong Medical Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Esophageal Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Esophageal Cancers Throws the Spotlight on Stenting as a Palliative Solution
    • Growing Adoption of Minimally Invasive Treatments Propels Demand for Esophageal Stents
    • Here's How Technological Advancements in Stent Design Strengthen the Business Case for Adoption
    • Expanding Use of Self-Expanding Metal Stents Drives Market Growth with Enhanced Clinical Outcomes
    • Increasing Preference for Endoscopic Procedures Generates Demand for Esophageal Stenting
    • Here's the Story: Rising Geriatric Population Sustains Growth in Demand for Dysphagia Management
    • Innovations in Anti-Migration and Anti-Reflux Features Expand the Addressable Market
    • Growing Incidence of Esophageal Strictures Spurs Demand for Safe and Effective Stent Solutions
    • Trend Toward Bioabsorbable Stents Expands Market Opportunity in Short-Term Therapeutic Applications
    • Here's How Increasing Use in Benign Conditions Generates New Market Opportunities
    • Rising Incidence of Gastroesophageal Reflux Disease (GERD) Creates Niche Growth Potential
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Esophageal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Esophageal Stents Market Analysis of Annual Sales in US$ for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Esophageal Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Esophageal Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Esophageal Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Esophageal Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030

IV. COMPETITION